MARKET

IBB

IBB

iShares Biotechnology ETF
NASDAQ
136.22
-1.11
-0.81%
Opening 11:07 06/14 EDT
OPEN
136.10
PREV CLOSE
137.33
HIGH
137.03
LOW
135.88
VOLUME
262.75K
TURNOVER
0
52 WEEK HIGH
141.16
52 WEEK LOW
111.62
TOTAL ASSET
7.44B
YTD YIELD
4.86%
1D
5D
1M
3M
1Y
5Y
Health Care Sector Update for 06/14/2024: CABA, VXRT, RARE, XLV, IBB
NASDAQ · 2h ago
The top ETFs with the most and the least options activity - Barclays
Seeking Alpha · 20h ago
Health Care Sector Update for 06/13/2024: BRTX, RGEN, PFE, XLV, IBB
NASDAQ · 1d ago
Is First Trust NYSE Arca Biotechnology ETF (FBT) a Strong ETF Right Now?
NASDAQ · 3d ago
How Is Regeneron Pharmaceuticals' Stock Performance Compared to Other Biotechnology Stocks?
Regeneron Pharmaceuticals, Inc. (REGN) is a leading biotechnology company with a market cap of $110.4 billion. Its shares are up 3.4% over the past three months, outperforming the broader Nasdaq Biotechnology Ishares ETF. REGN has been outperforming due to positive developments in its key drug, Eylea.
Barchart · 3d ago
Health Care Sector Update for 06/10/2024: SKYE, PROK, ZYME, XLV, IBB
NASDAQ · 4d ago
Weekly Report: what happened at IBB last week (0603-0607)?
Weekly Report · 4d ago
What The 2024 Elections Could Mean For Health Care Investors
Health care spending now accounts for 17% of the U.S. GDP. Election year volatility could mean opportunity for health care investors. The fate of medical exchanges and providers could be impacted by the election outcome. The outcome of the presidential election in 2024 could have implications for the health care sector.
Seeking Alpha · 6d ago
More
Profile
Fund Name
iShares Biotechnology ETF
Inception Date
2001-02-05
Benchmark
ICE Biotechnology TR USD
Advisor Company
BlackRock Fund Advisors
Custodian
JPMorgan Chase Bank NA
Manager
Greg Savage, Jennifer Hsui, Amy Whitelaw, Paul Whitehead